0001104659-19-030540.txt : 20190620 0001104659-19-030540.hdr.sgml : 20190620 20190520160539 ACCESSION NUMBER: 0001104659-19-030540 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS Ltd CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 CORRESP 1 filename1.htm

 

VIA EDGAR

 

May 20, 2019

 

U.S. Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4561
100 F Street, N.E.
Washington, D.C. 20549
Attention:  Chris Edwards and Liz Walsh

 

Re:                             Bicycle Therapeutics Ltd.
Acceleration Request for Registration Statement on Form S-1
File No. 333-231076

 

Acceleration Request

Requested Date:        May 22, 2019

Requested Time:       4:00 p.m., Eastern Time

 

Dear Mr. Edwards and Ms. Walsh:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Bicycle Therapeutics Ltd. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 22, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time.  In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

 

Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling James Xu at (617) 570-1483.  We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention:  James Xu, by facsimile to (617) 801-8920 or by email at JXu@goodwinlaw.com.

 

[Remainder of page left intentionally blank]

 

 

If you have any questions regarding this request, please contact James Xu of Goodwin Procter LLP at (617) 570-1483.

 

 

 

Sincerely,

 

 

 

 

 

Bicycle Therapeutics Ltd.

 

 

 

 

 

 

 

 

/s/ Kevin Lee

 

 

Kevin Lee, Ph.D., MBA

 

 

Chief Executive Officer

 

 

 

 

 

 

cc:

Kevin Lee, Bicycle Therapeutics Limited

 

 

 

Lee Kalowski, Bicycle Therapeutics Limited

 

 

 

Kristopher D. Brown, Goodwin Procter LLP

 

 

 

Jonathan A. Schur, Goodwin Procter LLP

 

 

 

Divakar Gupta, Cooley LLP

 

 

 

Ryan Sansom, Cooley LLP

 

 

 

Richard Segal, Cooley LLP

 

 

 

2